DTDaniel R. Trigo

Daniel R. Trigo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel R. Trigo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for multiple skin abscesses among community-recruited people who inject drugs in Los Angeles, CA, and Denver, CO: a cross-sectional study

    by Siddhi S. Ganesh, Gilbert A. Orta Portillo, Daniel R. Trigo, Katrina Ninh, Karina Dominguez Gonzalez, Patricia Wilkins, Eric Kovalsky, Karen F. Corsi, Joshua Barocas, Ricky N. Bluthenthal

    Introduction: Skin abscesses are one of the most common infections among people who inject drugs (PWID). Objective: To examine factors associated with the frequency of abscesses in the previous 3 months among PWID. Design: We conducted a cross-sectional analysis of baseline data from a prospective longitudinal cohort of PWID. Methods: Between April 2021 and November 2022, PWID were recruited from community settings in Los Angeles, CA, and Denver, CO. Participants completed an interview covering sociodemographic, drug use, and related risk behaviors. Participants were asked if they had abscesses in the last 3 months. Those reporting “ yes ” quantified the number of abscesses. Responses were classified as None , 1, or 2 or more . We used bivariate analysis and multi-nominal regression to examine factors associated with the frequency of abscesses. Results: Among participants ( n = 472), 62% reported no abscesses, 16% reported 1 abscess, and 22% reported 2+ abscesses in the last 3 months. Compared to participants with no abscess, 1 abscess was associated with receiving buprenorphine treatment (adjusted odds ratio (AOR) = 3.27; 95% CI = 1.58, 6.78), being injected by another person (AOR = 3.06; 95% CI = 1.72, 5.45), injecting 3+ times a day (as compared to less than daily, AOR = 2.92; 95% CI = 1.28, 6.65), licking syringe prior to injection (AOR = 1.96; 95% CI = 1.03, 3.74), and being Latino (AOR = 0.25; 95% CI = 0.12, 0.54). Having 2+ abscess was associated with daily heroin use (AOR = 2.35; 95% CI = 1.26, 4.39), being injected by another person (AOR = 1.92; 95% CI = 1.16, 3.18), daily methamphetamines use (0.50; 95% CI = 0.30, 0.83) and those reporting 10+ rushed injection (as compared to none, AOR = 1.85, 95% CI = 1.04, 3.29) in the last 3 months. Conclusion: Our findings underscore a multi-level approach to reducing abscesses in this population. Increased education around safe injection practices, institutional interventions—that is, addressing healthcare stigmatization and expanding clinical harm reduction—as well as structural interventions (safe supply, overdose prevention programs, housing) should be considered.


  • Open Access

    “We Weren’t Taught How to Cope With Tragedy”: Early Childhood Trauma, Grief, and Learned Coping Mechanisms Among People Who Inject Drugs

    by Erin E. Gould, Siddhi S. Ganesh, Daniel Trigo, Lizbeth Becerra, Amanda Cowan, Ricky N. Bluthenthal, Rachel Carmen Ceasar

    Background and objectives: Early traumatic exposure to factors such as household substance use, violence, and familial death increase the likelihood of substance use across a person’s lifespan. Our qualitative analysis sought to explore the social and relational drivers of substance use among people who inject drugs (PWID). Design and methods: We conducted qualitative interviews with 30 PWID (n = 30) in Los Angeles, CA from July 2021 to April 2022. To be eligible for this study, participants had to report being 18 years of age or older and self-report any opioid and injection drug use within the past 30 days. We used constructivist grounded theory to analyze the contexts that contribute to lived experiences surrounding familial trauma, resource scarcity, and substance use as a coping mechanism. Results: Participants in this study described drivers of current substance use patterns as related to childhood and familial trauma. These included: (1) early exposure to chaotic and/or disordered substance use by household members, (2) traumatic experiences, such as death of a family member, which they linked to substance use initiation, and (3) relying on substance use as a coping strategy which was modeled by family members. Conclusions: Early traumatic experiences and exposure to disordered substance use (ie, household family members using substances to emotionally regulate) combined with experiencing resource deprivation (ie, lacking trauma-informed mental health support and financial and wraparound care) contributed to participants’ experiences of substance use as a learned coping mechanism. Integrating social and structural support interventions, such as mental health service provision and financial stabilization services, into policy-making decisions may help to address the cyclical relationship between childhood exposure to trauma and adult substance use initiation.